Trials / Unknown
UnknownNCT02625064
Discovery of New Early Detection Biomarkers of Acute Respiratory Distress Syndrome
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 500 (estimated)
- Sponsor
- Xiangya Hospital of Central South University · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The goal of this project is to find a series novel biomarkers by differential proteomic techniques that can improve the early diagnosis and develop a more efficient therapy to enhance ARDS patient survival rate.
Detailed description
Acute respiratory distress syndrome(ARDS) has a very poor prognosis and high mortality. To improve the early diagnosis of ARDS, there is an urgent need for novel biomarkers of ARDS. The goal of this project is to find a series novel biomarkers by differential proteomic techniques that can improve the early diagnosis and develop a more efficient therapy to enhance ARDS patient survival rate. Clinical data and blood sample were recorded before treatment and after treatment. Acute Physiology And Chronic Health Evaluation III (APACHE III) scores were calculated at enrolment. Studying blood specimens from different period ARDS patients by proteomic analysis. It can provide information on a complex composition of proteins that are differentially expressed, which could be used for discovering high sensitivity and specificity ARDS biomarker.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Blood samples collection before treatment | |
| OTHER | Blood samples collection after treatment | |
| OTHER | laboratory biomarker proteomic analysis |
Timeline
- Start date
- 2016-01-01
- Primary completion
- 2019-01-01
- Completion
- 2019-01-01
- First posted
- 2015-12-09
- Last updated
- 2015-12-09
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT02625064. Inclusion in this directory is not an endorsement.